What are you looking for?
Need help finding what you are looking for? Contact Us

PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1479979

Cover Image

PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1479979

Global Molecular Diagnostics Market, Forecast to 2029

PAGES: 62 Pages
DELIVERY TIME: 1-2 business days
Web Access (Regional License)
USD 4950

Add to Cart

Molecular Diagnostics Unleash Growth Opportunities, Steering Innovation Personalized Medicine

The global molecular diagnostic market will experience significant growth due to a broad range of factors, such as increased demand from the COVID-19 pandemic, an increasing number of cancer cases, and the swift evolution of technological capabilities.

Technological advancements, such as polymerase chain reaction (PCR), digital PCR, and next-generation sequencing (NGS), have improved molecular testing accuracy and productivity, enabling personalized treatment.

The forecast analysis is segmented by region and by application. The latter includes infectious disease testing, oncology testing, genetic testing, and other molecular diagnostics. Frost & Sullivan's forecasts for this industry use a qualitative approach for the growth opportunity analyses due to methodological constraints.

The growing prevalence of cancer has accelerated the need for advanced molecular diagnostic tools, while the rise in chronic diseases, the modernization of government healthcare, and the growing demand for personalized medicine will contribute to the significant growth anticipated in the molecular diagnostics industry. Focused healthcare regulations and substantial R&D investments facilitate this expansion.

Product Code: PFEE-55

Table of Contents

Growth Environment

  • Growth Environment

Strategic Imperatives

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Global Molecular Diagnostics Industry
  • Strategic Imperatives for Global Molecular Diagnostics Companies
  • Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

  • Scope of Analysis
  • Global Molecular Diagnostics Application Segmentation


  • Growth Metrics
  • Growth Drivers
  • Growth Restraints
  • Forecast Assumptions

Revenue Forecast

  • Revenue Forecast
  • Global Molecular Diagnostics Revenue Forecast Analysis
  • Revenue Forecast by Region
  • Global Molecular Diagnostics Revenue Forecast Analysis by Region
  • Global Molecular Diagnostics Market Analysis by Technology
  • Revenue Forecast by Application
  • Global Molecular Diagnostics Revenue Forecast by Application

Competitive Landscape

  • Competitive Environment
  • Global Molecular Diagnostics Revenue Share by Player
  • Global Molecular Diagnostics Revenue Share Analysis
  • Key Competitors
  • Competitive Mapping by Molecular Diagnostics Offering

Mergers and Acquisitions

  • Global Molecular Diagnostics Market: Notable M&A

Companies to Watch

  • Molecular Diagnostics Companies to Watch

Growth Opportunity Universe

  • Growth Opportunity Summary
  • Growth Opportunity 1: Advancements in Point-of-care Testing
  • Growth Opportunity 2: Personalized Cancer Treatment Unveiling Genetic Markers and Therapies
  • Growth Opportunity 3: Leveraging Next-gen Molecular Diagnostics Technologies for Biomarker Development and Companion Diagnostics Integration
  • Growth Opportunity 4: Enhancing Home Health Monitoring

Next Steps

  • Your Next Steps
  • Why Frost, Why Now?
  • List of Exhibits
  • Legal Disclaimer
Have a question?

Jeroen Van Heghe

Manager - EMEA



Christine Sirois

Manager - Americas


Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!